Major depressive disorder affects thousands of Floridians, but 2026 brings promising new options beyond traditional antidepressants.
Recent advancements include COMP360 psilocybin showing strong phase 3 results for treatment-resistant depression, along with novel mechanisms like AMPA receptor modulators and at-home brain stimulation devices that received FDA clearance.
These innovations are particularly relevant for patients in Florida dealing with seasonal mood changes, hurricane-related stress, or long-standing treatment resistance.
